These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 36848363)

  • 1. The impact of adjuvant chemotherapy on survival in mucinous and non-mucinous rectal adenocarcinoma patients after TME surgery.
    Vernmark K; Knutsen A; Loftås P; Sun XF
    PLoS One; 2023; 18(2):e0282211. PubMed ID: 36848363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinicopathological characteristics and outcomes of colorectal mucinous adenocarcinoma: a retrospective analysis from China.
    Huang A; Yang Y; Sun Z; Hong H; Chen J; Gao Z; Gu J
    Front Oncol; 2024; 14():1335678. PubMed ID: 38380362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinicopathological features and prognosis analysis of proximal colonic mucinous adenocarcinoma.
    Han F; Xu Y; Li X; Song Z; Xie J; Yao J
    Sci Rep; 2024 Aug; 14(1):18682. PubMed ID: 39134655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Efficacy analysis of radiotherapy combined with surgery for locally advanced rectal mucinous adenocarcinoma: a retrospective study based on data of Surveillance, Epidemiology, and End results population].
    Zhang Y; Wang X; Chi P; Lin H; Lu X; Huang Y; Xu Z; Huang S; Sun Y; Ye D
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jan; 22(1):85-93. PubMed ID: 30703799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinicopathological and Molecular Features of Colorectal Cancer Patients With Mucinous and Non-Mucinous Adenocarcinoma.
    Lan YT; Chang SC; Lin PC; Lin CC; Lin HH; Huang SC; Lin CH; Liang WY; Chen WS; Jiang JK; Lin JK; Yang SH
    Front Oncol; 2021; 11():620146. PubMed ID: 33738258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjuvant chemotherapy improves long-term survival in pathologic stage III rectal mucinous adenocarcinoma after pre-operative chemoradiotherapy.
    Liao H; Li T; Liang Y; Liu Y; Yuan Y; Li M; Li A; Liu Y; Yao Y; Li T
    Int J Colorectal Dis; 2023 Aug; 38(1):207. PubMed ID: 37542591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjuvant chemotherapy for rectal cancer patients treated with preoperative (chemo)radiotherapy and total mesorectal excision: a Dutch Colorectal Cancer Group (DCCG) randomized phase III trial.
    Breugom AJ; van Gijn W; Muller EW; Berglund Å; van den Broek CBM; Fokstuen T; Gelderblom H; Kapiteijn E; Leer JWH; Marijnen CAM; Martijn H; Meershoek-Klein Kranenbarg E; Nagtegaal ID; Påhlman L; Punt CJA; Putter H; Roodvoets AGH; Rutten HJT; Steup WH; Glimelius B; van de Velde CJH
    Ann Oncol; 2015 Apr; 26(4):696-701. PubMed ID: 25480874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjuvant Chemotherapy Does Not Improve Recurrence-Free Survival in Patients With Stage 2 or Stage 3 Rectal Cancer After Neoadjuvant Chemoradiotherapy and Total Mesorectal Excision.
    Voss RK; Lin JC; Roper MT; Al-Temimi MH; Ruan JH; Tseng WH; Tam M; Sherman MJ; Klaristenfeld DD; Tomassi MJ
    Dis Colon Rectum; 2020 Apr; 63(4):427-440. PubMed ID: 31996583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adjuvant chemotherapy improves overall survival after TME surgery in mucinous carcinoma of the rectum.
    Chand M; Rasheed S; Bhangu A; Stamp GW; Swift RI; Tekkis PP; Brown G
    Eur J Surg Oncol; 2014 Feb; 40(2):240-5. PubMed ID: 24286808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mucinous histology is associated with poor prognosis in locally advanced colorectal adenocarcinoma treated with postoperative first-line adjuvant chemotherapy: A systematic review and meta-analysis.
    Zhang Y; Chen Y; Huang J; Wu X; Tang R; Huang Q; Xu Y; Peng X; Fu K; Xiao S
    Eur J Surg Oncol; 2022 Oct; 48(10):2075-2081. PubMed ID: 35768312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Upfront radical surgery with total mesorectal excision followed by adjuvant FOLFOX chemotherapy for locally advanced rectal cancer (TME-FOLFOX): an open-label, multicenter, phase II randomized controlled trial.
    Lee JB; Kim HS; Jung I; Shin SJ; Beom SH; Chang JS; Koom WS; Kim TI; Hur H; Min BS; Kim NK; Park S; Jeong SY; Baek JH; Kim SH; Lim JS; Lee KY; Ahn JB
    Trials; 2020 Apr; 21(1):320. PubMed ID: 32264919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of stage, grade, and mucinous histology on the efficacy of systemic chemotherapy in adenocarcinomas of the appendix: Analysis of the National Cancer Data Base.
    Asare EA; Compton CC; Hanna NN; Kosinski LA; Washington MK; Kakar S; Weiser MR; Overman MJ
    Cancer; 2016 Jan; 122(2):213-21. PubMed ID: 26506400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does Adjuvant Chemotherapy for Locally Advanced Resectable Rectal Cancer treated with Neoadjuvant Chemoradiotherapy have an impact on survival? A Single Moroccan Institute Retrospective Study.
    Seddik Y; Brahmi SA; Afqir S
    Gulf J Oncolog; 2019 May; 1(30):29-32. PubMed ID: 31242979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adjuvant Chemotherapy After Preoperative Chemoradiation Improves Survival in Patients With Locally Advanced Rectal Cancer.
    Sun Z; Gilmore B; Adam MA; Kim J; Hsu SD; Migaly J; Mantyh CR
    Dis Colon Rectum; 2017 Oct; 60(10):1050-1056. PubMed ID: 28891848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial.
    Bahadoer RR; Dijkstra EA; van Etten B; Marijnen CAM; Putter H; Kranenbarg EM; Roodvoets AGH; Nagtegaal ID; Beets-Tan RGH; Blomqvist LK; Fokstuen T; Ten Tije AJ; Capdevila J; Hendriks MP; Edhemovic I; Cervantes A; Nilsson PJ; Glimelius B; van de Velde CJH; Hospers GAP;
    Lancet Oncol; 2021 Jan; 22(1):29-42. PubMed ID: 33301740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Local recurrence and survival rate after rectal cancer operations and multimodal therapy].
    Thomschke D; Kyau-Ummen B; Halbfass HJ
    Chirurg; 2002 Mar; 73(3):245-54. PubMed ID: 11963499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adjuvant radiotherapy improves cause specific survival in stage II, not stage III mucinous carcinoma of the rectum.
    Li Q; Li Y; Dai W; Wang S; Xu Y; Li X; Cai S
    BMC Cancer; 2017 Jan; 17(1):80. PubMed ID: 28122523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjuvant Radiotherapy Is Not Necessary for Stage III Mucinous Rectal Cancer: Evidence Based on Long Survival Analysis from SEER Data.
    Liao H; Tang C; Zhou Z; Shi H; Li T; Liang Y; Li M; Li T; Lei X
    J Gastrointest Surg; 2023 Dec; 27(12):2857-2866. PubMed ID: 37989932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk stratification of stage II rectal mucinous adenocarcinoma to predict the benefit of adjuvant chemotherapy following neoadjuvant chemoradiation and surgery.
    Liang Y; Liao H; Shi H; Li T; Liu Y; Yuan Y; Li M; Li A; Liu Y; Yao Y; Li T
    Front Oncol; 2024; 14():1352660. PubMed ID: 38511138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mucinous and Non-Mucinous Rectal Adenocarcinoma-Differences in Treatment Response to Preoperative Radiotherapy.
    Vernmark K; Sun XF; Holmqvist A
    J Pers Med; 2020 Nov; 10(4):. PubMed ID: 33202796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.